ARCHIVES

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

This article is from The Cancer Letter archive.

Vol. 14 No. 45 | November 18, 1988

Download PDF Visit The Full Archive

Related Articles

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

October 24, 1975

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

Nixon to Receive ACCC Annual Award

January 10, 1986

Trial Begins To Test Method To Test For Colorectal Cancer

May 28, 2004